Director Reproductive Toxicologist

About the Company

About the Role

Responsibilities

• ● As a Senior Reproductive Toxicologist, you will provide expert scientific leadership and strategic guidance across AstraZeneca's portfolio, supporting programmes ranging from discovery through late-stage development, registration, and post-marketing activities.
• ● Providing expert interpretation of developmental, reproductive and juvenile toxicology data and translating findings into development and regulatory strategy.
• ● Partnering with multidisciplinary project teams to support clinical development plans, regulatory submissions, health authority interactions and product labelling.
• ● Advising on reproductive safety assessments, inclusion of women of childbearing potential and paediatric populations in clinical development programmes.
• ● Designing and overseeing reproductive toxicology programmes that support global development and registration strategies across multiple therapeutic areas and modalities.
• ● Contributing to governance discussions and presenting reproductive toxicology positions to project teams.
• ● Supporting interactions with global regulatory agencies and contributing to responses to regulatory questions.
• ● Representing AstraZeneca in external scientific forums, industry collaborations and consortia related to reproductive toxicology and paediatric development.
• ● Contributing to the continued evolution of AstraZeneca's reproductive toxicology strategy, including innovative approaches that advance science and reduce animal usage.

Requirements

• ● We are looking for an experienced reproductive toxicologist with strong scientific judgement, strategic thinking and the ability to influence across multidisciplinary teams.
• ● You will bring:
• ● Considerable industry experience applying developmental and reproductive toxicology expertise, including experience supporting one or more of: marketing applications, health authority interactions, regulatory submissions or product labelling.
• ● Demonstrated experience supporting late-stage clinical development, marketing applications, product labelling and post-marketing activities.
• ● Strong knowledge and practical application of relevant global regulatory guidelines, including ICH M3, S5, S6, S9 and S11.
• ● Experience supporting health authority interactions and regulatory submissions across global regions (EMA, PMDA, CDE and FDA).
• ● Demonstrated expertise in the interpretation and strategic application of developmental, reproductive and juvenile toxicology data.
• ● Excellent communication and interpersonal skills, with the ability to influence and collaborate effectively within multidisciplinary global teams.
• ● The ability to balance scientific rigour with pragmatic decision-making in a fast-paced development environment.
• ● The following would be advantageous:
• ● Experience supporting paediatric development programmes.
• ● Exposure to a broad range of therapeutic modalities.
• ● Experience supporting innovative approaches to reproductive safety assessment.
• ● Experience participating in external scientific working groups, consortia or industry initiatives.

Benefits

• ● This role offers a rare opportunity to apply reproductive toxicology expertise across the entire drug development lifecycle. You will work on a diverse portfolio of innovative medicines, engage with a broad network of scientific and clinical experts, and contribute directly to development strategies that impact patients around the world.
• ● You'll join a supportive and collaborative team of reproductive toxicology specialists where scientific excellence, partnership and continuous learning are highly valued. Whether supporting regulatory strategy, influencing clinical development, or contributing to industry-wide scientific initiatives, you will play a key role in advancing AstraZeneca's commitment to delivering medicines that make a meaningful difference to patients.
• ● Interested Apply now by submitting your CV together with a cover letter
• ● Date Posted 24-Sept-2026
• ● Closing Date 09-Oct-2026